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Abstract: This article reviews some of the ethical issues that arise in environmental health research with human subjects, 
such as minimizing risks to subjects, balancing beneﬁ  ts and risks in research, intentional exposure studies with human 
subjects, protecting third parties in research, informing subjects about environmental hazards, communicating health infor-
mation to subjects, and protecting privacy and conﬁ  dentiality.
Introduction
Since the U.S. adopted regulations governing research with human subjects in the 1970s, most of the 
ethical debates about research with human subjects have focused on questions relating to clinical 
research, such as management of risks, using placebos in control groups, randomization, informed 
consent, reporting adverse events, recruitment of subjects, and research on vulnerable populations. Most 
of the infamous or controversial cases discussed in the literature on human experimentation—the Nazi 
Experiments, the Tuskegee Syphilis Study, the Department of Energy’s secret human radiation experi-
ments, and HIV research in developing nations—have been about medical research conducted in a 
clinical setting (Coleman et al. 2005; Emanuel et al. 2008; Levine 1988). In the last ﬁ  ve years, however, 
ethical issues in environmental health research with human subjects have drawn greater attention (Resnik 
et al. 2005; Resnik and Zeldin, 2008; Resnik and Wing, 2007; Resnik, 2008; Resnik, 2006; Institute of 
Medicine, 2005; National Research Council, 2004; Sharp, 2003). Most of the ethical issues that occur 
in environmental health research are similar to those that arise in clinical research, but since there are 
important scientiﬁ  c, social, and political differences between environmental health research and clini-
cal research, these familiar issues appear under a new light. This article will review some of the more 
challenging ethical issues in environmental health research.
Environmental Health Research with Human Subjects
To understand some of the ethical issues in environmental health research with human subjects, it is 
important to distinguish between different research methods used by investigators, since these methods 
generate different ethical questions and problems. Environmental health research methods involving 
human subjects can be classiﬁ  ed as either observational or experimental. Observational studies gather 
information about human subjects in their natural environment, whereas experiments gather information 
on human subjects under controlled conditions. Some of the designs commonly used in observational 
research include case-control studies, cohort studies, ﬁ  eld studies, and cross-sectional studies. These 
study designs are commonly used in epidemiological and medical research. In a retrospective case-
control study, investigators collect information on the environmental exposures of a group of people 
with a disease or condition (cases) over a period of time and a group of people similar to the cases but 
who do not have the disease or condition in question. In a prospective cohort study, investigators follow 
one group of people (the cohort) who have a particular characteristic (such as an environmental expo-
sure) for a long period of time (10 years or more). Investigators also follow a comparison group of 
people (the control group) who do not have the characteristic. Field studies are similar to prospective 
cohort studies, except the observational period is much shorter: a ﬁ  eld study may involve observation 
of subjects over a period involving days, weeks, or months. In a cross-sectional study, investigators 
make observations of a population at a single point in time. In all of these methods, investigators attempt 28
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to determine whether observed differences between 
the groups (e.g. cases vs. controls or cohort vs. 
control) are due to differences in environmental 
exposures (Gertsman, 2003).
Experimental research with human subjects 
includes intentional exposure studies and interven-
tional studies in a particular environment, such as 
a home, workplace, hospital, or school. Intentional 
exposure studies expose human subjects to a safe 
dosage of an environmental agent, such as ozone, 
dust, or allergens, under controlled conditions, 
such as a laboratory.
2 Intentional exposure studies 
can help investigators to obtain a better under-
standing of causal pathways from exposure to 
disease (National Research Council, 2004). Inter-
ventional studies expose a group of subject (the 
experimental group) to an environmental health 
intervention (such as lead abatement or educational 
materials). Interventional studies usually also 
include a control group that is not exposed to the 
intervention. The control group may be exposed 
to a different intervention or none at all (Institute 
of Medicine, 2005).
Basic Requirements for Ethical 
Research
Over the last three decades, ethicists, researchers, 
and scholars have come to recognize some basic 
requirements for ethical research with human sub-
jects (see Shamoo and Resnik, 2008; Emanuel et al. 
2000 for further discussion):
1.  Scientific validity: research should well-
designed and executed; the use of human 
subjects must be necessary to answer scientiﬁ  c 
questions.
2.  Social value: research should be expected to 
produce beneﬁ  ts for society.
3.  Risk minimization: risks to human subjects 
should be minimized.
4. Beneﬁ  t/risk justiﬁ  cation: the expected beneﬁ  ts 
of the study to the subjects or society must 
outweigh the potential risks to the subjects.
5.  Informed consent: research subjects (or their 
representatives) should give their informed 
consent to participate in research.
6.  Protection of conﬁ  dentiality and privacy: the 
conﬁ  dentiality and privacy of subjects should 
be protected to the extent allowable by law.
7.  Equitable subject selection: the selection of 
subjects must be equitable; there must be a 
sound scientific or moral justification for 
including subjects in research or excluding 
them from research.
8.  Protection of vulnerable subjects: vulnerable 
subjects, such as children, prisoners, or men-
tally disabled adults, should be protected from 
harm or exploitation in research.
9.  Data and safety monitoring: research should 
be monitored to protect subjects from harm and 
ensure the integrity of the data.
10. Independent review: an independent commit-
tee, such as an institutional review board (IRB), 
should review and oversee research.
These ethical requirements are embodied in various 
legal rules and policies, including the U.S. federal 
research regulations (e.g. 45 C.F.R. 46 and 21 
C F.R. 50, 56), the Nuremberg Code, the World 
Medical Association’s Declaration of   Helsinki, and 
the Good Clinical Practice Guidelines (Coleman 
et al. 2005). These ethical requirements apply to 
all types of research, including environmental 
health research. This review will discuss several 
issues relating to the application of these require-
ments to environmental health research.
Beneﬁ  ts and Risks
One of the important ethical differences between 
observational and experimental studies in environ-
mental health research is that observational studies 
usually impose fewer risks on research subjects 
than experimental ones, because observational 
studies collect data on people in their natural envi-
ronment (Resnik and Wing, 2007). Observational 
studies usually impose risks on subjects that are 
not greater than the risks subjects would ordinarily 
encounter in daily life, which are defined as 
“minimal risks” under the federal research regula-
tions (see 45 C.F.R. 46.102(i)). For example, a 
prospective cohort study of farm workers that asks 
subjects to complete a questionnaire and health 
survey every ﬁ  ve years and provide 5 ml of blood 
for genetic analysis would impose few risks beyond 
the risk of loss of conﬁ  dentiality, which could be 
minimized by taking protective measures, such as 
securing data and controlling access to it. A ﬁ  eld 
study of pesticide applicators that measures pesti-
cide residue on the subjects before and after the 
workday and also measures pesticide metabolites 
excreted in the urine would also impose few risks 
beyond the risk of the loss on conﬁ  dentiality. 
Although the subjects would be exposed to pesti-
cides at work, this exposure would have occurred 29
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even if they did not participate in the study, thus, 
it is not a risk imposed by the study. The study adds 
only the risks of collecting a urine sample and 
pesticide residue, completing surveys and ques-
tionnaires, and potential loss of conﬁ  dentiality.
Experimental studies may impose risks on 
research subjects that are more than minimal. For 
example, the Human Studies Division of the Envi-
ronmental Protection Agency (EPA) has an expo-
sure laboratory for conducting studies on the 
effects of air pollution on the human respiratory 
system. Subjects in different experiments are 
exposed to ozone, automobile emissions, or other 
pollutants under controlled conditions. Scientists 
measure the subjects’ responses to these exposures, 
and monitor the subjects’ medical condition (EPA, 
2008). Some experiments that expose subjects to 
pollutants involve a bronchoscopy to examine the 
airway and collect a small piece lung tissue for 
analysis (Arjomandi et al. 2005). A bronchoscopy 
is a medical procedure in which a physician inserts 
a tube (known as bronchoscope) into a patient’s 
airways through the nose or mouth. The patient is 
usually sedated. The risks of a bronchoscopy 
include bronchial spasms, difﬁ  culty breathing, 
bleeding, cardiac arrhythmias, infections, hoarse-
ness, and a 0.1% to 0.01% chance of death, depend-
ing on the patient and the procedure (WebMD, 
2008; Rose and Knox, 2007).
Imposing more than minimal risks on research 
subjects who are not expected to receive any 
medical beneﬁ  ts from the research can be ethically 
controversial. Since the subjects will receive little 
or no beneﬁ  ts from their participation, the research 
can be justiﬁ  ed only if it is expected to yield impor-
tant beneﬁ  ts for society, such as the development 
of new medical treatments.
1 For example, Phase 
I trials of new drugs on healthy subjects usually 
involve risks that are more than minimal but offer 
the participants no beneﬁ  ts. The risks of any par-
ticular Phase I trial depend on the type of drug 
being tested, but there is often a small but very real 
chance of death, permanent injury, or disability. 
These studies can be ethically justiﬁ  ed, according 
to most commentators, because they are a neces-
sary step in the development of new drugs to treat 
diseases (Shamoo and Resnik, 2006).
More than minimal risk environmental health 
research experiments, such as the exposure studies 
mentioned above, do not usually beneﬁ  t society by 
paving the way for new medical treatments. Nev-
ertheless, one might argue that these studies can 
be justiﬁ  ed if they are expected to yield important 
biomedical knowledge that will help to promote 
and protect public health and they are not expected 
to cause permanent harm to the participants 
(Resnik, 2006). For example, exposing human 
subjects to ozone may help researchers better 
understand how ozone impairs lung function, 
which could lead to changes in preventative health 
recommendations or air pollution regulations. To 
justify these experiments, it is essential for inves-
tigators to take precautions necessary to minimize 
risks to the subjects, such as using inclusion/
exclusion criteria to disqualify potential subjects 
who have an increased risk for developing health 
problems when participating in lung function stud-
ies, careful monitoring of subjects during the test-
ing period, follow-up with subjects after the testing 
period, using a data and safety monitoring com-
mittee to oversee the research, and implementing 
effective procedures for reporting adverse events 
(Resnik, 2006).
If experiments that expose research subjects to 
ozone can be ethically justiﬁ  ed, what about exper-
iments that expose subjects to pesticides? Some 
private companies have conducted pesticide 
experiments on human subjects, exposing people 
to minute amounts of chemicals that can be toxic 
or deadly in larger doses. Some commentators have 
argued that these experiments are unethical, 
because they do not offer society any important 
beneﬁ  ts. Companies designed these experiments 
in order to generate data to convince regulatory 
agencies to weaken pesticide registration rules 
(Environmental Working Group, 1998; Goldman 
and Links, 2004). Others argue that even if these 
particular experiments were not justiﬁ  ed, some 
pesticide experiments could be justiﬁ  ed if they are 
expected yield important public health beneﬁ  ts 
(such as stricter pesticide regulations) and they 
satisfy stringent scientiﬁ  c and ethical standards 
(Resnik and Portier, 2005; National Research 
Council, 2004). The ethical issues concerning 
pesticide testing on human subjects have not been 
resolved, and this remains a controversial topic in 
environmental health research.
In the fall of 2004 a ﬁ  eld study designed and 
funded by the EPA and Centers for Disease Control 
and Surveillance (CDC), with ﬁ  nancial support 
from the American Chemistry Council (ACC), 
named the Children’s Environmental Exposure 
Study (CHEERS), became ensnared in the contro-
versy concerning pesticide experiments on human 30
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subjects (Resnik and Wing, 2007). The aim of the 
study was to observe children’s exposures to 
pesticides and other chemicals in the home. Fam-
ilies with high pesticide use were invited to par-
ticipate in the study, which also would include a 
control group of families with low pesticide use. 
The investigators planned to monitor pesticide 
exposures during a series of 30 visits to the home 
over a two-year period. The protocol called for 
investigators to take surface wipe samples from 
around the home and urine samples from the chil-
dren. They would also ask parents to record their 
children’s activities with a video camera and to 
keep records of pesticide use in the home. Parents 
were not required to start using pesticides to be in 
study, and they could remain in the study even if 
they decided to stop using pesticides. The investi-
gators planned to warn parents about unsafe uses 
of pesticides and dangerous pesticide levels 
detected in the home or the children. Parents would 
receive a free video camera and $970 if they com-
pleted all of the study activities. The three IRBs 
that reviewed the study classiﬁ  ed it as minimal risk 
(Resnik and Wing, 2007).
The study was initiated in the fall of 2004. 
Critics charged that CHEERS was an intentional 
exposure study that treated children like guinea 
pigs. They argued that the investigators were plan-
ning to conduct a controlled experiment in which 
parents would be asked to expose their young 
children to pesticides in return for a considerable 
sum of money. Critics also claimed that the study 
targeted low-income groups and that support from 
the ACC constituted an unacceptable conﬂ  ict of 
interest (Organic Consumers Association, 2005). 
EPA ofﬁ  cials and investigators were planning to 
revise the study to deal with these criticisms, but 
they were unable to convince politicians and the 
public that the study should go forward. Bowing 
to political pressure, the EPA cancelled the study 
in the spring of 2005 (Resnik and Wing, 2007). 
One of the important lessons from the demise of 
CHEERS is that environmental health researchers 
who are conducting observational studies should 
take steps to avoid creating the perception that their 
work intentionally exposes people to environmen-
tal agents, such as pesticides. The protocol and the 
informed consent document should be designed to 
clearly communicate to all parties that the research 
is observational, not experimental. Participants 
should not be asked to change their environmental 
exposures in order to be in the study or required to 
not change their exposures in order to remain in 
the study (Resnik and Wing, 2007).
Issues pertaining to beneﬁ  ts and risks have also 
arisen in research on environmental health inter-
ventions, such as studies of lead abatement or mold 
remediation (Resnik, 2008; Institute of Medicine, 
2005). In a study that has received considerable 
attention due to a lawsuit related to the research, 
investigators from the Kennedy Krieger Institute 
at Johns Hopkins University conducted a con-
trolled trial on the effects of different types of lead 
abatement on houses with lead paint located in 
Baltimore, NY. Twenty-ﬁ  ve low-income families 
with young children were enrolled in the study. 
They were randomly assigned to one of three 
experimental groups or two control groups. The 
experimental groups included families living in 
homes that received different degrees of lead abate-
ment, but less than the full amount of abatement, 
while the control groups included families living 
in lead-free homes or homes that had received the 
full amount of lead abatement. The goal of the 
study was to determine whether less than the full 
amount of lead abatement is an effective method 
of preventing health hazards related to lead expo-
sure in the home. Many people living in homes 
with lead paint (or their landlords) could not afford 
the thousands of dollars required for full abatement 
(Grimes v. Kenney Krieger Institute, 2001).
One of the issues in the Kennedy Krieger study 
was whether it was ethical to not offer full lead 
abatement to all of the families living in homes 
with lead paint, since full lead abatement was the 
standard procedure for minimizing the health haz-
ards of lead paint (Institute of Medicine, 2005). 
Some critics of the study argued that denying full 
lead abatement to subjects in the experimental 
groups was analogous to denying an effective treat-
ment to patients in a clinical trial of a new medica-
tion (Spriggs, 2004). There is a consensus among 
medical ethicists that patients with a serious 
medical condition should not be denied and effec-
tive treatment when one is available, because 
clinical investigators have an ethical duty to pro-
vide their patients/subjects with the standard of 
care (London, 2000). Defenders of the lead abate-
ment study responded to this charge by claiming 
that the study was different from a clinical trial, 
because the investigators were not physicians and 
the subjects were not their patients. Hence, the 
investigators did not have an obligation to provide 
all of the subjects with full lead abatement; they 31
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only had an obligation to avoid exploiting the 
subjects. The study was not exploitative because 
it beneﬁ  tted the subjects, who received some lead 
abatement. The study also beneﬁ  tted the commu-
nity (Buchan and Miller, 2006). These are complex 
issues that bear further investigation and analysis. 
Although environmental health investigators are 
usually not physicians with a duty to promote their 
health of their patients/subjects, they should take 
steps to ensure that research subjects are not 
harmed and the beneﬁ  ts and burdens of research 
are distributed fairly (Resnik, 2008).
It is also important to note that some environ-
mental health studies impose risks on people who 
are not directly involved in research, i.e. third 
parties. For example, an environmental health 
invention in the home may impose risks on people 
who are not research subjects, such as occupants 
of the home, or a study of agricultural workers may 
impose risks on farmers who employ the workers 
(Resnik and Sharp, 2006). Addressing risks to third 
parties in research is ethically controversial, 
because most regulations and guidelines do not 
address risks to third parties. The federal research 
regulations, for example, only mention obligations 
to minimize risks to research subjects (Resnik and 
Sharp, 2006). Since human research regulations 
do not mention risks to third parties, some writers 
have questioned whether researchers and IRBs 
should address these risks at all. Others have 
argued that there is an ethical obligation to address 
third party risks based on the notion that research-
ers should avoid causing harm. Hence, researchers 
and IRBs should address risks to third parties, when 
these risks can be identiﬁ  ed and prevented (Resnik 
and Sharp, 2006).
Sharing Information with Subjects
Informed consent requirements in environmental 
health research are very similar to those in clinical 
research. Investigators must inform subjects about 
the goals, methodsand procedures used in research; 
beneﬁ  ts, risks, alternatives, conﬁ  dentiality protec-
tions; the right to withdraw from research; and 
whom to contact for more information. Consent 
forms should be written in language that is under-
standable to the subject, and consent discussions 
should also take place under circumstances that 
minimize the potential for coercion or undue inﬂ  u-
ence. Consent should be documented, except in 
circumstances that involve procedures in which 
consent is not normally documented or the main 
risk of the research is loss conﬁ  dentiality and the 
consent document is the only information linking 
the subject to the research (Department of Health 
and Human Services, 2005).
One of the consent issues unique to environ-
mental health research is informing subjects (or 
their families) about the risks present in their envi-
ronment. When researchers collect data on hazards 
in the home or work environment, they have an 
obligation to inform subjects about those risks, 
because subjects need to know about these risks to 
make an informed choice (Institute of Medicine, 
2005; Resnik and Zeldin, 2008). For example, 
investigators in the CHEERS study had planned 
to inform parents about dangerous pesticide expo-
sures and unsafe pesticide practices. One of the 
allegations made by the plaintiffs in the Kennedy 
Krieger lawsuit was that the investigators did not 
inform the parents about dangerous lead levels in 
their children in a timely fashion (Grimes v. 
Kennedy Krieger Institute, 2001). Although clini-
cal researchers inform subjects about study-related 
risks, they usually do not inform subjects about 
risks present in the subjects’ environment.
Investigators may be reluctant to inform subjects 
about environmental risks because the subjects 
may decide to not enroll in the study, drop out of 
the study, or take steps that would affect the data. 
For example, consider a study of pesticide use in 
the home. If a family participating in the study is 
informed about the risks of pesticide use, they may 
decide to stop using pesticides rather than enroll 
in a study of pesticide use, or they may decide to 
drop out of the study, or they may decide to 
decrease their use of pesticides. Although investi-
gators should be prepared to deal with the decisions 
that subjects may make when they receive informa-
tion, they should not withhold information from 
subjects or potential subjects to control their behav-
ior. Investigators should design their research to 
compensate for subjects’ decisions in response to 
the information they receive. For example, inves-
tigators could ensure that enrollment is high 
enough to compensate for potential withdrawals, 
and that data is collected and analyzed in a way 
that changes in the subject’s behavior will not 
signiﬁ  cantly affect the results. Investigators should 
also be prepared to counsel subjects about risks 
that are discovered in the environment and to make 
referrals, so that subjects can take steps to reduce 
these risks (Institute of Medicine, 2004).32
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During an inspection of a home, worksite, or 
other environmental setting, investigators may 
become aware of hazards that are not directly related 
to the study but are discovered while conducting the 
study, also known as incidental ﬁ  ndings (Illes et al. 
2008). For example, while inspecting a house for 
mold, an investigator may also detect unstable stairs 
in the basement, wasp nests in the attic, or other 
problems that could pose a risk to the occupants. 
Researchers must decide whether to disclose these 
incidental ﬁ  ndings to the occupants of the home. An 
argument for disclosure is that researchers have an 
ethical obligation to protect research subjects (and 
third parties) from harm, including harm that is 
incidental to the research study. If an investigator 
smells a gas leak in the basement during a mold 
inspection, it would be callous and irresponsible not 
to inform the occupants of the home about the leak. 
An argument against disclosure is that investigators 
may not have the knowledge or expertise to assess 
or discuss findings that are unrelated to their 
research. Additionally, subjects also do not expect 
to receive reports of such ﬁ  ndings. Most environ-
mental health researchers are not trained as electri-
cians, plumbers, or home inspectors. One suggested 
solution to the dilemma concerning incidental ﬁ  nd-
ings is to disclose only those ﬁ  ndings that a reason-
able person would disclose under the circumstances, 
rather than the ﬁ  ndings that an expert would disclose 
(Resnik and Zeldin, 2008).
Other types of information that investigators 
may consider sharing with research subjects 
include the results of tests conducted as part of  the 
study, such as blood tests or genetic tests. The main 
reason to share these results with subjects is that 
they may contain information they can use to pro-
tect their health. For example, a parent would want 
to know if her child has elevated lead levels in her 
bloodstream, because she could use that informa-
tion to decide whether her child should see a phy-
sician or whether she should take steps to reduce 
the child’s exposure to lead. Likewise, a family 
would want to know if their house contains an 
abnormally high amount of mold, because they 
could use that information to reduce mold levels.
The argument against sharing results from test 
conducted for research purposes is that they may 
be useless to the subjects or even uninformative. 
For example, researchers who are conducting a 
study to determine whether there are genetic vari-
ants that increase susceptibility to the adverse 
effects of mercury exposure may not know whether 
the information about genetic variants will be 
useful to subjects in making medical decisions. The 
data may be useful in discovering associations 
between genes and diseases or generating hypoth-
eses, but not useful in making medical decisions. 
Subjects who learn about these test results ﬁ  nd the 
information to be useless or even confusing. 
According to some authors, the results of tests 
conducted for research purposes should be returned 
to subjects only if the tests are reliable and accurate, 
and the information is likely to useful to subjects in 
making medical decisions (Renegar et al. 2006).
Privacy and Conﬁ  dentiality
Most of the conﬁ  dentiality and privacy issues in 
environmental health research with human subjects 
are similar to those that arise in clinical research. 
For example, environmental health researchers 
should restrict access to data, store data in a secure 
place using secure methods, and remove informa-
tion from the data that identiﬁ  es individuals prior 
to publication. Investigators may remove all per-
sonal identiﬁ  ers from the data if this information 
is not needed for research purposes. Investigators 
should also inform subjects about the measures 
that will be taken to protect their privacy and con-
ﬁ  dentiality (Shamoo and Resnik, 2008).
Some conﬁ  dentiality and privacy issues are 
unique to environmental health research. When 
environmental health researchers conduct ﬁ  eld 
studies in homes, businesses, or other venues, they 
may gain access to private information that is not 
part of the study (Institute of  Medicine, 2005). For 
example, investigators conducting a study of aller-
gen reduction in the home may ﬁ  nd out about drug 
or alcohol use, sexual activity, health or psycho-
logical problems, and so on. Investigators should 
protect the privacy of their subjects and keep this 
information in conﬁ  dence, unless they discover 
evidence of abuse of a child or vulnerable adult. 
Investigators should also inform subjects about 
their obligation to report evidence of the abuse of 
a child or vulnerable adult during the consent 
process (Resnik and Zeldin, 2008). In general, 
investigators should use discretion and good judg-
ment when collecting data in the home, to avoid 
unnecessary disclosures of private information.
Conclusion
This review has highlighted some of the ethical 
issues that arise in environmental health research 33
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with human subjects. There are of course some 
important issues that this review has not covered 
in depth, including conﬂ  icts of interest, payments 
to subjects, consulting with communities, and 
research with vulnerable populations.
3 As one can 
see from this brief survey, the ethical issues that 
arise in environmental health research with human 
subjects are similar to those that arise in clinical 
research, but there are some situations unique to 
environmental health research that create dilemmas 
rarely encountered by clinical researchers. Many 
of these novel ethical dilemmas occur when inves-
tigators collect data or conduct interventions in the 
home environment or intentionally expose human 
subjects to dangerous environmental agents, such 
as pesticides. It is likely that other novel issues will 
emerge in environmental health research. Environ-
mental scientists—and ethicists—should prepare 
to deal with them as they arise.
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Notes
1. Although subjects usually receive some payment 
for risk research that does not provide any 
medical beneﬁ  ts, most government agencies do 
not consider money to be a beneﬁ  t. See Shamoo 
and Resnik (2006).
2. A “safe” dosage would be one that is not 
expected to cause any permanent harm to the 
research subject. Some substances that are 
harmful in larger doses, such as ozone, may 
cause little harm in very small doses. Some 
substances may cause permanent harm even in 
small doses. For example, known carcinogens, 
such as benzene and asbestos can cause perma-
nent damage at very small exposures. It makes 
no difference whether the unsafe expose might 
occur in normal life. For example, a construc-
tion worker might inhale asbestos dust when 
helping to demolish an old building, but this 
would not justify intentionally exposing a 
human subject to inhaled asbestos. For further 
discussion, see Resnik (2006), National 
Research Council (2004).
3. For further discussion of conﬂ  icts of interest in 
biomedical research and research with vulner-
able populations, see Shamoo and Resnik 
(2008); for discussion of payments to subjects, 
see Grady (2005); for discussion of community 
consultation in research, see Weijer and 
Emanuel (2000).
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